BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butalbital, Acetaminophen, Caffeine And Codeine Phosphate, and when can generic versions of Butalbital, Acetaminophen, Caffeine And Codeine Phosphate launch?
Butalbital, Acetaminophen, Caffeine And Codeine Phosphate is a drug marketed by Able, Hikma, Hikma Intl Pharms, Lgm Pharma, Nostrum Labs Inc, and Strides Pharma. and is included in six NDAs.
The generic ingredient in BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE?
- What are the global sales for BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE?
- What is Average Wholesale Price for BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE?
Summary for BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 5 |
DailyMed Link: | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE at DailyMed |
Pharmacology for BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Drug Class | Barbiturate Central Nervous System Stimulant Methylxanthine Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Physiological Effect | Central Nervous System Stimulation |